And for many of the banks, the big boost to earnings which came out of improvement in asset quality given that most large banks including SBI now have net NPAs at 0.5-0.6% or lower, from next year that benefit also will not be there to add to the earnings.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the